本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Day One Biopharmaceuticals Inc.

7.90
+0.46006.18%
盘后7.900.00000.00%16:37 EDT
成交量:114.33万
成交额:876.22万
市值:8.01亿
市盈率:-7.71
高:7.91
开:7.41
低:7.35
收:7.44
数据加载中...
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/11/07

重要事件披露

8-K - Current report
2022/11/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/02

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/31

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/10/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/12

重要事件披露

8-K - Current report
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/24

重要事件披露

8-K - Current report
2022/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/16

重要事件披露

8-K - Current report
2022/06/13

重要事件披露

8-K - Current report
2022/06/08

SEC问询函

CORRESP [Cover] - Correspondence